Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
O.F.I. S.p.A. (Officina Farmaceutica Italiana) is a leading Italian contract development and manufacturing organization (CDMO) specializing in the pharmaceutical, dermocosmetic, and dietary supplement industries. Founded in 1946 and headquartered in Bergamo, the company provides end-to-end services ranging from formulation research and development to large-scale production and packaging. OFI is recognized for its expertise in creating innovative health and beauty products, including medical devices and specialized nutritional supplements. The company operates state-of-the-art manufacturing facilities that comply with international quality standards such as GMP and ISO. With a strong focus on R&D, OFI partners with global brands to bring high-quality healthcare products to market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OFI.